Aurinia Pharmaceuticals Inc. (AUPH) income statement
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3057% below fair value
$14.70−0.19 (-1.28%)
Close on Nov 20, 2026Market cap $1.97BP/E 6.4Yield –
Aurinia Pharmaceuticals Inc. financial ratios
See a number that looks wrong?